Browsing: 21B

By the numbers   Q1 sales: $11.16 billion 7.8% increase year over year   Medical device sales: $5.54B About 13%…

Abbott said it has received all regulatory clearances necessary to buy the cancer screening firm. Source link

Abbott’s roughly $21 billion acquisition of cancer screening firm Exact Sciences lays out the company’s future strategy. Analysts said the…

The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection. Source…